Zacks Investment Management Cytokinetics Inc Transaction History

Zacks Investment Management

  • $11.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$10.82 - $14.25 $118,814 - $156,479
-10,981 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$7.95 - $11.25 $61,668 - $87,266
-7,757 Reduced 41.4%
10,981 $124,000
Q1 2019

May 15, 2019
BUY
$5.95 - $10.19 $111,491 - $190,940
18,738 New
18,738 $152,000
Q2 2018

Aug 14, 2018
SELL
$6.9 - $9.9 $116,389 - $166,993
-16,868 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$7.2 - $10.05 $121,449 - $169,523
16,868 New
16,868 $121,000

Others Institutions Holding CYTK

# of Institutions
409
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.57B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Zacks Investment Management Portfolio

Follow Zacks Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email